Skip to content
OpenCapital
Get started

Dogwood Therapeutics DWTX Quick ratio

Quick ratio at other companies

Eli Lilly logo
Eli LillyLLY
1.1×0.0×
Pfizer logo
PfizerPFE
1.2×0.0×
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
2.6×+0.3×
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
1.7×+0.7×
Bioventus logo
BioventusBVS
1.1×+0.2×
Avanos Medical logo
Avanos MedicalAVNS
1.4×-0.2×

Other financials

Income statement

See full
Operating income-$5.1M-14.6%
Net income-$5.0M+54.4%
EPS (diluted)-$0.15+98.2%

Balance sheet

See full
Cash & equivalents$13.2M-24.6%
Total debt$144.9K-24.2%
Total equity$80.6M+1,038%
Total assets$95.2M-1.8%

Cash flow

See full
Operating cash flow-$4.6M+2.0%

Valuation

See full
Market cap$54.14M-57.6%
Enterprise value$41.06M-64.7%

Returns & leverage

See full
Return on equity-64.6%-29.8pp
Debt / equity0×0.0×
Current ratio5.9×-1.6×

Where this comes from

Calculated from Dogwood Therapeutics’s reported figures.

quick assets/total current liabilities=5.9×

Based on the most recent quarter.

The official record: Dogwood Therapeutics’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dogwood Therapeutics's quick ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Dogwood Therapeutics's quick ratio?
Dogwood Therapeutics (DWTX) reported quick ratio of 5.9× in Q1 2026.
How has Dogwood Therapeutics's quick ratio changed year-over-year?
Dogwood Therapeutics's quick ratio decreased by 21.1% year-over-year, from 7.4× to 5.9×.
What is the long-term trend for Dogwood Therapeutics's quick ratio?
Over 5 years (2020 to 2025), Dogwood Therapeutics's quick ratio has grown at a -33.1% compound annual growth rate (CAGR), from 20.5× to 2.8×.
What does quick ratio mean?
Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.